• Publications
  • Influence
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
Reproducibility is a current concern for everyone involved in the conduct and publication of biomedical research. Recent attempts testing reproducibility, particularly the reproducibility project inExpand
  • 143
  • 54
  • PDF
Experimental design and analysis and their reporting: new guidance for publication in BJP
This Editorial is part of a series. To view the other Editorials in this series, visit: http://onlinelibrary.wiley.com/doi/10.1111/bph.12956/abstract;Expand
  • 903
  • 41
  • PDF
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.
Delta(9)-tetrahydrocannabinol binds cannabinoid (CB(1) and CB(2)) receptors, which are activated by endogenous compounds (endocannabinoids) and are involved in a wide range of physiopathologicalExpand
  • 519
  • 39
  • PDF
Flavonoids: old and new aspects of a class of natural therapeutic drugs.
Flavonoids are natural products widely distributed in the vegetable kingdom and currently consumed in large amounts in the daily diet. Flavonoids are capable of modulating the activity of enzymes andExpand
  • 1,202
  • 19
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacology (Curtis et al., 2015) and is intended to provide the rubric for peer review. Thus,Expand
  • 487
  • 18
  • PDF
Cannabinoids and the gut: new developments and emerging concepts.
Cannabis has been used to treat gastrointestinal (GI) conditions that range from enteric infections and inflammatory conditions to disorders of motility, emesis and abdominal pain. The mechanisticExpand
  • 316
  • 17
  • PDF
Cannabinoid CB1‐receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
We have studied the effect of cannabinoid agonists (CP 55,940 and cannabinol) on intestinal motility in a model of intestinal inflammation (induced by oral croton oil in mice) and measuredExpand
  • 238
  • 16
Interactions Between Herbal Medicines and Prescribed Drugs
The concomitant use of herbal medicines and pharmacotherapy is wide spread. We have reviewed the literature to determine the possible interactions between seven popular herbal medicines (ginkgo, StExpand
  • 381
  • 14
A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies
Systematic reviews and meta‐analyses represent the uppermost ladders in the hierarchy of evidence. Systematic reviews/meta‐analyses suggest preliminary or satisfactory clinical evidence for agnusExpand
  • 205
  • 14
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
Aim:  Plant cannabinoids, like Δ9‐tetrahydrocannabinol (THC) and cannabidiol (CBD), activate/desensitize thermosensitive transient receptor potential (TRP) channels of vanilloid type‐1 or ‐2 (TRPV1Expand
  • 154
  • 13